ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
트라실롤(아프로티닌) 시장 규모는 향후 몇 년간 강한 성장세를 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 심혈관 질환의 발생률 증가, 고급 의료 치료에 대한 관심 증가, 유전적 및 진단 검사 접근성 향상, 만성 질환 발생률 증가, 수술 절차 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 고급 의료 기술 및 의약품의 채택, 트라넥삼산이 임상 지침에 통합, 개발 도상국 시장에서 항섬유소 용해제 의약품의 채택, 스포츠 의학에서의 새로운 응용 분야, 환자 안전 및 맞춤형 의약품에 대한 관심 등이 있습니다.
수술 건수의 증가는 트라실롤(아프로티닌) 시장의 성장을 촉진할 것으로 예상됩니다. 만성 생활 습관병의 증가는 의료 기술의 발전을 촉진하여 수술을 더욱 효과적이고 접근하기 쉽게 만들었습니다. 그 결과, 수술에 대한 수요가 증가하고 있습니다. 프로테아제 억제제인 트라실롤은 역사적으로 관상 동맥 우회술(CABG)과 같은 수술에서 출혈을 줄이고 수혈의 필요성을 최소화하기 위해 사용되었습니다. 예를 들어, 2023년 12월 영국 보건 보안청(UK Health Security Agency)은 CABG 수술이 2023년에 2만 7,524건으로 증가했다고 보고했습니다. 이러한 수술 건수의 증가는 트라실롤에 대한 수요를 증가시킬 가능성이 높습니다.
출혈 장애의 발병률 증가는 트라실롤 시장 성장에 기여하는 주요 요인입니다. 혈액의 응고 능력을 저하시키는 출혈 장애는 과다 출혈을 유발할 수 있습니다. 이러한 증가는 진단 기술의 발전, 인식 제고, 유전적 요인 및 노화 요인과 같은 요인에 기인할 수 있습니다. 트라실롤(아프로티닌)은 심장 수술과 같은 고위험 수술에서 섬유소 용해 작용을 억제하고 혈전을 안정화하여 과다 출혈을 방지하기 위해 수술 현장에서 일반적으로 사용됩니다. 2022년 10월, 세계 혈우병 연맹은 혈우병과 폰 빌레브란트 병을 포함한 전 세계 출혈 장애 사례가 42만 7,685건이라고 보고했습니다. 출혈 장애의 발병률이 증가함에 따라 트라실롤(아프로티닌)에 대한 수요도 증가할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 트라실롤(아프로티닌) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 트라실롤(아프로티닌) 시장 : 성장률 분석
세계의 트라실롤(아프로티닌) 시장 실적 : 규모와 성장(2019-2024년)
세계의 트라실롤(아프로티닌) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 트라실롤(아프로티닌) : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 트라실롤(아프로티닌) 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2043년)
천연 아프로티닌
재조합 아프로티닌
세계의 트라실롤(아프로티닌) 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2043년)
병원 약국
소매 약국
온라인 플랫폼
세계의 트라실롤(아프로티닌) 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2043년)
심장 수술
정형외과 수술
기타 의료 처치
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 트라실롤(아프로티닌) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2043년)
세계의 트라실롤(아프로티닌) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2043년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
트라실롤(아프로티닌) 시장 : 경쟁 구도
트라실롤(아프로티닌) 시장 : 기업 프로파일
Pfizer Inc.
Bayer AG
Bristol-Myers Squibb Company
Novartis AG
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
트라실롤(아프로티닌) 시장(2029년) : 새로운 기회를 제공하는 국가
트라실롤(아프로티닌) 시장(2029년) : 새로운 기회를 제공하는 부문
트라실롤(아프로티닌) 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Trasylol, the brand name for aprotinin, is a medication used to reduce bleeding and the need for transfusions during major surgeries, such as heart surgery. It works by inhibiting enzymes that break down blood clots, but it has been under scrutiny due to potential risks, including kidney dysfunction.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary types of trasylol (aprotinin) are natural aprotinin and recombinant aprotinin. Natural aprotinin is a protein extracted from bovine lungs, used to prevent excessive bleeding during surgery by inhibiting the breakdown of blood clots. It is distributed through hospital pharmacies, retail pharmacies, and online platforms for various medical procedures, including cardiac surgeries, orthopedic surgeries, and others.
The trasylol (aprotinin) market research report is one of a series of new reports from The Business Research Company that provides trasylol (aprotinin) market statistics, including trasylol (aprotinin) industry global market size, regional shares, competitors with a trasylol (aprotinin) market share, detailed trasylol (aprotinin) market segments, market trends and opportunities, and any further data you may need to thrive in the trasylol (aprotinin) industry. This trasylol (aprotinin) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry
The trasylol (aprotinin) market size is expected to see strong growth in the next few years. It will grow to $3,24,920 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to the rising prevalence of cardiovascular diseases, growing focus on advanced medical treatments, rising availability of genetic and diagnostic tests, rising prevalence of chronic disease, and increasing number of surgical procedures. Major trends in the forecast period include the adoption of high-end medical technologies and pharmaceuticals, the integration of tranexamic acid in clinical guidelines, the adoption of antifibrinolytic drugs in developing markets, emerging applications in sports medicine, and a focus on patient safety and personalized medicine.
The increasing number of surgical procedures is expected to drive the growth of the trasylol (aprotinin) market. The rise in chronic lifestyle diseases has led to more advancements in medical technology, making surgeries more effective and accessible. As a result, the demand for surgical procedures is on the rise. Trasylol, a protease inhibitor, was historically used during surgeries like coronary artery bypass grafting (CABG) to reduce blood loss and minimize the need for blood transfusions. For example, in December 2023, the UK Health Security Agency reported an increase in CABG surgeries, with 27,524 surgeries conducted in 2023. This growing volume of surgical procedures is likely to boost the demand for trasylol.
The growing incidence of bleeding disorders is key factor contributing to the growth of the trasylol market. Bleeding disorders, which impair the blood's ability to clot properly, can result in excessive bleeding. This rise can be attributed to factors such as improved diagnosis, increased awareness, and genetic and aging factors. Trasylol (aprotinin) is commonly used in surgical settings to prevent excessive blood loss in high-risk surgeries, such as cardiac surgery, by inhibiting fibrinolysis and stabilizing blood clots. In October 2022, the World Federation of Hemophilia reported 427,685 global cases of bleeding disorders, including hemophilia and von Willebrand disease. This growing incidence of bleeding disorders is expected to drive demand for Trasylol (aprotinin).
A key trend in the trasylol market is the exploration of inhaled aprotinin as a potential treatment for SARS-CoV-2 infections. This research focuses on repurposing aprotinin as a protease inhibitor in the treatment of COVID-19 when administered via inhalation. For example, in April 2022, Kent University in the UK and Goethe University in Germany partnered to study the use of aprotinin in treating COVID-19. Their research demonstrated that aprotinin could inhibit viral entry, and clinical trials showed positive outcomes, including reduced hospital stays. This collaboration underscores the potential for repurposing existing treatments like Trasylol for emerging health crises, which could expand the market further.
Key player operating in the trasylol (aprotinin) market is Bayer AG
North America was the largest region in the trasylol (aprotinin) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in trasylol (aprotinin) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the trasylol (aprotinin) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The trasylol market consists of sales of products including tranexamic acid, aminocaproic acid, generic aprotinin injections, and desmopressin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Trasylol (Aprotinin) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on trasylol (aprotinin) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for trasylol (aprotinin) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The trasylol (aprotinin) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Natural Aprotinin; Recombinant Aprotinin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Platforms
3) By Application: Cardiac Surgeries; Orthopedic Surgeries; Other Medical Procedures
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Trasylol (Aprotinin) Market Characteristics
3. Trasylol (Aprotinin) Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Trasylol (Aprotinin) Market Trends And Strategies
5. Trasylol (Aprotinin) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Trasylol (Aprotinin) Growth Analysis And Strategic Analysis Framework
6.1. Global Trasylol (Aprotinin) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Trasylol (Aprotinin) Market Growth Rate Analysis
6.4. Global Trasylol (Aprotinin) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Trasylol (Aprotinin) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Trasylol (Aprotinin) Total Addressable Market (TAM)
7. Global Trasylol (Aprotinin) Market Pricing Analysis & Forecasts
8. Trasylol (Aprotinin) Market Segmentation
8.1. Global Trasylol (Aprotinin) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Aprotinin
Recombinant Aprotinin
8.2. Global Trasylol (Aprotinin) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Platforms
8.3. Global Trasylol (Aprotinin) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac Surgeries
Orthopedic Surgeries
Other Medical Procedures
9. Global Trasylol (Aprotinin) Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Trasylol (Aprotinin) Market Regional And Country Analysis
10.1. Global Trasylol (Aprotinin) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Trasylol (Aprotinin) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
